Working longer hours and body weight: An Australian study using household panel data (with measures of paid and unpaid time) to provide gender-specific estimates.

SSM Popul Health

National Centre for Epidemiology and Population Health (NCEPH), College of Health and Medicine, The Australian National University, Canberra, 2601, Australia.

Published: December 2023

Time is a resource for health, and when time is constrained, people have less opportunity to maintain good health. This study focuses on the relationship between paid work hours (with a focus on long hours) and body weight for Australian men and women. Time is conceptualised as a 24-hour system, including time in paid work, time in unpaid work, and discretionary time (available for health promoting activities). We propose that to accurately estimate the relationship between long paid work hours and body weight, analyses need to take account of unpaid work hours, and that this is particularly important for women. Analyses utilised 16 waves of data from the Household, Income and Labour Dynamics in Australia (HILDA) panel study, with data on hours in paid and unpaid work and BMI at all waves (n = 113,084 observations, 54,664 from women and 58,424 from men). We used Mixed Effects models with a Two Stage Residual Inclusion (2SRI) approach to account for time unobserved heterogeneity and the reciprocity between time uses (paid and unpaid) and body weight. The results showed that for every 10 hours worked above the gender-specific average, women weighed 762 grms more and men weighed 1.34 kgs more. When the analyses were restricted to sedentary jobs this increased to 938 grms for women and 1.68 kgs for men. We contribute new evidence highlighting the importance of including unpaid work hours in research that aims to understand working time and health.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10709171PMC
http://dx.doi.org/10.1016/j.ssmph.2023.101561DOI Listing

Publication Analysis

Top Keywords

body weight
16
work hours
16
unpaid work
16
hours body
12
paid unpaid
12
paid work
12
time
10
weight australian
8
time paid
8
time health
8

Similar Publications

Drug Development.

Alzheimers Dement

December 2024

Department of Anesthesiology and Critical Care, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, U.S.A., Philadelphia, PA, USA.

Background: The vicious cycle between depression and dementia increases the risk of Alzheimer's Disease (AD) pathogenesis and pathology. This study investigates therapeutic effectiveness versus side effects and the underlying mechanisms of intranasal dantrolene nanoparticles (IDNs) to treat depression behavior and memory loss in 5XFAD mice.

Method: 5XFAD and wild-type B6SJLF1/J mice were treated with IDNs (IDN, 5 mg/kg) in Ryanodex formulation for a duration of 12 weeks.

View Article and Find Full Text PDF

Drug Development.

Alzheimers Dement

December 2024

School of Medical & Allied Sciences, K.R. Mangalam University, Gurugram, Haryana, India.

Background: Parkinson's disease is an hypokinetic disorder characterized by selective loss of dopaminergic in substantia nigra pars compacta (SNPc) region of mid-brain. Dopaminergic degeneration of neurons is considered to be due to oxidative stress, neuroinflammation, neurons mitochondrial dysfunction and glutamate excitotoxicity etc. Filgrastim has been reported to produce anti-oxidant, anti-inflammatory and neuromodulatory actions in previous studies.

View Article and Find Full Text PDF

Drug Development.

Alzheimers Dement

December 2024

Department of Anesthesiology and Critical Care, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, U.S.A., Philadelphia, PA, USA.

Background: This study investigates the therapeutic versus side effects of intranasal lithium chloride (LiCl) in Ryanodex formulation vehicle (RFV) to inhibit inflammation and pyroptosis and to ameliorate on cognitive dysfunction and depressive behavior in 5XFAD mice.

Method: 5XFAD and wild type (WT) B6SJLF1/J mice were treated with intranasal or oral LiCl (3 mM/kg) dissolved in RFV starting at 2 or 9 months old and the continuous treatment lasted for 12 weeks. Behavior was examined for depression, cognition, olfaction, and motor function at the ages of 5 or 12 months.

View Article and Find Full Text PDF

Background: Microbiota of the distal part of the intestine produces Urolithin A (Uro A) as a derivative of ellagitannins hydrolysis. Recently, the mitophagy, anti-inflammatory, and antioxidant properties of Uro A have focused more attention on its probable beneficial effects on neurodegenerative states. The purpose of this research was to study the impact of Uro A on the histopathology of the cerebellum in a rat model of streptozotocin-induced Alzheimer's disease.

View Article and Find Full Text PDF

Drug Development.

Alzheimers Dement

December 2024

ProMIS Neurosciences, Toronto, ON, Canada.

Background: A large body of evidence now indicates that the most pathogenic species of Aß in Alzheimer's disease (AD) consist of soluble toxic oligomers (AßO) as opposed to insoluble fibrils and monomers. Using our computational platform, we identified 4 different AßO-restricted conformational B cell epitopes (300, 301, 303, 305) that were tested as vaccines for their ability to induce an antibody response that selectively targets toxic AßO, without inducing potentially detrimental B or T cell responses against plaque or normal Aß. A novel ex vivo approach was then used to select an optimal vaccine configuration amongst the 15 possible combinations of the 4 epitopes to provide maximal binding to a toxic oligomer-enriched low molecular weight (LMW) fraction of soluble AD brain extracts.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!